13th February 2025 ,Kolkata, India – Pushpanjali Eye Hospital is proud to announce an exciting breakthrough in the treatment of retinal diseases through innovative RNA therapeutics. Led by Dr. Prashant Srivastava, this new approach marks a significant step forward in the fight against a range of retinal conditions, offering hope to millions of patients worldwide.

Dr. Prashant Srivastava, a renowned retina specialist, and his team have been at the forefront of researching and developing RNA-based treatments for retinal diseases. This innovative therapeutic approach focuses on using RNA molecules to directly target and correct the underlying causes of conditions like age-related macular degeneration (AMD), diabetic retinopathy, and inherited retinal diseases.

Revolutionizing Retinal Care:

Retinal diseases, particularly those affecting the macula, are among the leading causes of blindness globally. Traditionally, treatments have been limited to managing symptoms or slowing disease progression. However, RNA therapeutics represent a shift in how these diseases are treated. By using RNA to correct or modify specific genetic instructions within the retina, Dr. Srivastava and his team aim to offer more precise, long-lasting solutions.

The approach leverages the power of RNA to repair or replace defective genes within retinal cells, potentially restoring vision or halting disease progression altogether. This cutting-edge treatment represents a new frontier in ophthalmology, with the potential to transform the lives of patients who currently have limited options.

A Personalized Approach:

What sets RNA therapeutics apart from traditional methods is the ability to tailor treatments to individual patients. With advancements in genetic testing, doctors can now identify specific mutations in the patient's retinal cells, allowing for personalized RNA treatments that target the root cause of the disease. This level of precision is expected to improve outcomes and reduce side effects, offering a more effective and safer treatment for retinal diseases.

Dr. Prashant Srivastava shared his excitement about the breakthrough: "This is a groundbreaking moment in the field of retinal care. We are no longer just managing the symptoms of retinal diseases—we are working to treat them at the genetic level. RNA therapeutics offer new hope for patients who have long struggled with vision loss, and we are proud to be leading this innovation."

What Does This Mean for Patients?

For patients suffering from retinal diseases, RNA therapeutics offer a future filled with promise. The ability to address genetic issues directly within the retina means that doctors can potentially halt the progression of conditions that previously led to irreversible vision loss. In some cases, it may even be possible to restore vision that was thought to be lost forever.

Pushpanjali Eye Hospital’s commitment to bringing these innovative treatments to the forefront reflects its dedication to improving patient outcomes. With the introduction of RNA-based therapies, the hospital aims to provide patients with the most advanced and effective care available.

Visit: https://pushpanjalieyecare.com/